Publication | Open Access

Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice

Her2/neu-derived Peptide Ae37Tumor ModelPeptide EngineeringImmunologyPeptide TherapeuticPeptide ScienceImmunotherapeuticsTumor TargetingBalb/c MiceImmunotherapyMedicineRadiation Oncology